WithdrawnPhase 2ketamine

Ketamine and Midazolam Infusions for CRPS: Feasibility Study

Sponsored by Stanford University

NCT ID
NCT05945147
0
Start Date
2099-01-01
Est. Completion
2099-05-31

About This Study

This study will assess the feasibility of administering ketamine plus midazolam or midazolam alone, when infused over 5 days in an outpatient setting, to adults with complex regional pain syndrome (CRPS).

Conditions Studied

Complex Regional Pain Syndromes

Interventions

  • •Ketamine
  • •Midazolam
  • •Normal Saline

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
* Age 18 to 65 years
* Meets the International Association for the Study of Pain (IASP) diagnostic criteria for complex regional pain syndrome (CRPS)
* Primary complaint of CRPS-attributable pain for ≥3 months
* Average pain intensity of ≥3/10 over the last month
* Can read and comprehend English-language questionnaires
* Can receive text messages by phone
* Can identify a responsible adult who can provide transportation to and from infusion site for 5 consecutive days (Mon-Fri)

Study Locations (1)

Stanford University
Stanford, California, United States

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Ketamine and Midazolam Infusions for CRPS: Feasibility Study | Huxley